Nuvectis Pharma Inc. (NVCT)
NASDAQ: NVCT
· Real-Time Price · USD
6.33
-0.10 (-1.56%)
At close: Aug 15, 2025, 10:06 AM
-1.56% (1D)
| Bid | 6.29 |
| Market Cap | 161.01M |
| Revenue (ttm) | 26.8M |
| Net Income (ttm) | -22.07M |
| EPS (ttm) | -1.16 |
| PE Ratio (ttm) | -5.45 |
| Forward PE | -5.5 |
| Analyst | Buy |
| Ask | 6.43 |
| Volume | 12,051 |
| Avg. Volume (20D) | 174,170 |
| Open | 6.45 |
| Previous Close | 6.43 |
| Day's Range | 6.33 - 6.45 |
| 52-Week Range | 4.44 - 11.80 |
| Beta | -0.27 |
About NVCT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVCT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-7.81%
Nuvectis Pharma shares are trading lower after the...
Unlock content with
Pro Subscription
9 months ago
-46.3%
Nuvectis Pharma shares are trading lower. The company reported data from its Phase 1b study evaluating NXP800.
